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To determine the usefulness of noninvasive cutaneous 
swab specimens for detecting rickettsiae, we tested skin es-
chars from 6 guinea pigs and from 9 humans. Specimens 
from eschars in guinea pigs were positive for rickettsiae as 
long as lesions were present. Optimal storage temperature 
for specimens was 4°C for 3 days.
R
ickettsiae are a group of obligate, intracellular, gram-
negative bacteria. The family Rickettsiaceae includes 
the genera Rickettsia and Orientia ( 1). Rickettsiae are 
transmitted to humans by arthropods (2) and cause diseases 
characterized by fever, headache, rash, and vasculitis (3). 
An infection eschar is commonly found at the site of the ar-
thropod bite because of local multiplication of the bacteria. 
Incidence of infection with rickettsiae is increasing world-
wide (4) in certain disease-endemic foci, and seasonal, 
sporadic (5,6), and occasionally epidemic forms have been 
reported (7). Over the past 20 years, advances in molecular 
techniques and cell culture have facilitated identiﬁ  cation 
of Rickettsiales, and new species and diseases have been 
described (4,8). Recently, a new Rickettsia species, 364D, 
was identiﬁ  ed in patients from California (9).
Eschar biopsies are used for detection of Rickettsia 
spp., but this technique is invasive and painful for patients 
and is difﬁ  cult to perform for certain areas of the body. Suc-
cessful diagnosis in patients by using rapid, noninvasive, 
and painless techniques is beneﬁ  cial. One study reported 
the usefulness of swabs of skin lesions in the diagnosis of 
3 cases of Queensland tick typhus and 1 case of African 
tick bite fever (10). In addition, eschar crust samples were 
useful in the diagnosis of 1 case of infection with Orientia 
tsutsugamushi, the infectious agent of scrub typhus (11). 
To evaluate the potential usefulness of swabs of skin le-
sions for rickettsial diagnosis, we evaluated this procedure 
for eschars from 6 guinea pigs and 9 patients.
The Study
The animal study was conducted beginning in Febru-
ary 2009, and the human study was conducted beginning in 
June 2009. R. conorii, R. akari, R. rhipicephali, R. africae, 
R. parkeri, and O. tsutsugamushi were grown in L929 cell 
monolayers, puriﬁ  ed, and titrated as reported (12). A sus-
pension of each rickettsial species (200 μL containing 1 × 
105 rickettsia) was injected intradermally into 8 shaved ar-
eas on the backs of 6 Hartley guinea pigs (1 species/guinea 
pig) by using aseptic procedures (12). A negative control 
guinea pig was infected with 200 μL (1 × 106 cells/mL) of 
an L929 cell suspension. Infection sites were inspected dai-
ly for skin lesions. Animals were handled according to the 
regulations of Décret No. 887–848 du 10/19/1987, Paris. 
The experimental protocol was reviewed and approved by 
the Institutional Animal Care Committee, Université de la 
Méditerranée, Marseille. 
Infection with each rickettsial species caused an es-
char at the infection site (12). Eschars were observed at day 
3 postinfection. A sterile cotton swab (Copan Italia S. p. 
A., Brescia, Italy) was rotated against the eschar (3 circu-
lar motions) and stored at 4°C for 24 h. Swabs were then 
placed in 400 μL of phosphate-buffered saline, and DNA 
was extracted by using the QIAamp DNA Mini Kit (QIA-
GEN, Hilden, Germany). Lesions were swabbed daily until 
the animal showed clinical recovery (day 20 postinfection 
for those infected with R. akari, R. conorii, and R. rhipi-
cephali and day 13 postinfection for those infected with R. 
africae, R. parkeri, and O. tsutsugamushi).
Maximum number of DNA copies for R. rhipicephali, 
R. akari, and R. conorii was detected on day 4 postinfection 
(2.27 × 107, 2.96 × 107, and 9.28 × 107copies/5 μL of swab 
DNA extracts, respectively (Figure 1, panel A). Maximum 
number of DNA copies for R. parkeri was detected on day 
3 postinfection (2.66 × 105 copies/5 μL), for R. africae on 
day 6 postinfection (6.73 × 105 copies/5 μL), and for O. 
tsutsugamushi on day 10 postinfection (2.7 × 107 copies/5 
μL) (Figure 1, panel B).
Effects of temperature and storage time of cotton 
swabs on bacterial DNA were evaluated in 3 guinea pigs 
infected with R. conorii. Twelve swabs per animal were 
obtained daily for 5 days and stored in groups of 3 at 22°C, 
4°C, −20°C, or −80°C. DNA was extracted after 1, 2, or 
3 days of storage. Eschars appeared by day 3 postinfec-
tion and reached their maximum size by day 7. Storage at 
4°C was the optimal temperature condition for isolation of 
DNA (7.53 × 106 copies/5 μL vs. 1.03 × 106, 3.77 × 106, or 
4.49 × 106 copies/5 μL for swab storage at 22°C, −20°C, or 
−80°C respectively; p = 0.0001) (Figure 2, panel A). Stor-
age time (24 h, 48 h, and 72 h) had no effect on DNA yield 
(Figure 2, panel B). Temperature had a signiﬁ  cant effect 
(p<0.05) on DNA yield and for the same extraction (Figure 
2, panels C–E).
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for detection of rickettsial infection, we used this tech-
nique with eschars from patients with suspected rickettsio-
ses. Nine patients were included in this experiment after 
informed consent was obtained. This experiment was re-
viewed and approved by the local ethics committee (ref-
erence 09–016). DNA was extracted from swabs or skin 
biopsy specimens and tested by quantitative PCRs (qPCRs) 
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Figure 2. Effect of temperature (A), storage time (B), and temperature and storage times (C–E) on yield of rickettsial DNA, Marseille, 
France. Guinea pigs (n = 3) were infected with Rickettsia conorii and inspected daily for skin lesions. After lesions appeared, 12 swab 
specimens/animal were obtained daily for 5 days and stored in groups of 3 at 22°C, 4°C, −20°C, or −80°C. DNA was extracted after storage 
for 24 h, 48 h, or 72 h at each temperature in a ﬁ  nal volume of 100 μL, and numbers of bacterial DNA copies were quantiﬁ  ed in 5 μL of 
swab DNA extracts by using quantitative PCR. Box plots indicate 25th and 75th percentiles, horizontal lines indicate medians, and error 
bars indicate minimum and maximum values.
Figure 1. Molecular detection of Rickettsia spp. in swabs of skin lesions, Marseille, France. Guinea pigs were infected intradermally 
with different Rickettsia spp., and skin eschar swab specimens were obtained when lesions appeared. Samples (2 ± 1 mg) were tested, 
and DNA was extracted in a ﬁ  nal volume of 100 μL. Number of rickettsial DNA copies was determined by quantitative PCR until day 20 
postinfection for R. akari (black line), R. conorii (red line), and R. rhipicephali (blue line) (A) and until day 13 postinfection for R. africae 
(black line), Orientia tsutsugamushi (red line), and R. parkeri (blue line) (B). Values are copies of citrate synthase A gene/5 μL swab 
extract. Identiﬁ  cation of Rickettsial Infections
(13) speciﬁ  c for a fragment of the citrate synthase A gene, 
which is conserved among spotted fever group rickettsiae, 
or the gene coding periplasmic serine protease of O. tsut-
sugamushi; β-actin gene was used as a control (14).
When rickettsial DNA was ampliﬁ  ed in samples, spe-
ciﬁ  c qPCR was performed by using speciﬁ  c primers and 
probes and on the basis of clinical and epidemiologic data 
(online Technical Appendix Table 1, www.cdc.gov/EID/
content/17/1/83-Techapp.pdf) (4). If speciﬁ  c  rickettsial 
DNA was not detected, PCR ampliﬁ  cation and sequencing 
were performed to identify the causative agent (4,15). R. 
montanensis DNA was used as a positive control, and DNA 
from sterile biopsy samples and sterile water were used as 
a negative control.
The qPCR for the β-actin gene showed cycle threshold 
(Ct) values of 19–23 for skin biopsy samples and 22–37 
for swab samples (Table). Spotted fever group rickettsial 
DNA was detected in biopsy samples from 5/5 patients and 
swab samples from 8/9 patients (online Technical Appen-
dix Table 2). Speciﬁ  c qPCR showed a diagnostic result in 
3/7 swabs samples and 4/5 skin biopsy samples.
We ampliﬁ  ed R. conorii DNA from patients 1 and 2, 
R. africae DNA from patients 4 and 5, and R. australis 
DNA from patient 9. Rickettsial DNA from patients 3 and 
7 showed 100% homology with the R. sibirica mongoli-
timonae citrate synthase A gene (GenBank accession nos. 
DQ097081 and DQ423370, respectively). Rickettsial DNA 
from patient 6 showed 99.1% homology with DNA from R. 
slovaca. Patient 9 was a technician who was accidentally 
infected by the aerosol route when handling R. australis. 
Only 2/11 swabs obtained from vesicular lesions of patient 
9 were positive for rickettsial DNA and R. australis DNA 
after reampliﬁ  cation of primary PCR products. These sam-
ples showed 98% homology with R. australis 23S rRNA 
gene (GenBank accession no. AJ133711) (online Technical 
Appendix Table 2).
Conclusions
Our study showed the efﬁ  cacy and reliability of skin 
lesion swabs for molecular detection of 6 Rickettsia spe-
cies (Figure 1). Rickettsial DNAs were detected by using 
this technique as long as eschars persisted (<19 days). For 
short-term storage of swabs, 4°C was the optimal tem-
perature. Using swabs of eschars, we made a diagnosis of 
rickettsiosis for 8/9 patients. For patients 6, 7, and 8, for 
whom biopsy samples were not available, we conﬁ  rmed the 
diagnosis by using swab samples. We also showed that for 
patient 9, who had a rickettsiosis but no eschar, swabbing 
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1 1 22.27 33.91  36.63  19.39  29.03  32.52  R. conorii
2 1 29.73 Neg  Neg  21.21 29.32  33.29  R. conorii
3 1 22.32 30.99  Neg  18.89  28.72  Neg  R. sibirica 
mongolitimonae
4 1 24.48 35.21  34.15  22.92  31.92  26.66  R. africae
5 1 31.13 34.67  Neg  20.68  33.66  31.9 R. africae
6§ 1 35.49 35.29  Neg  – – – R. slovaca
7§ 1 24.78 30.63  ND  – – – R. sibirica 
mongolitimonae
8§ 1 24.19 Neg  Neg  – – – R. conorii
1 23.36 Neg  Neg  – – – –
1 21.94 37.97  Neg  – – – –
1 35.50 Neg  Neg  – – – –
9§¶ 1 32.50 Neg  Neg  – – – R. australis
1 32.05 Neg  Neg  – – – –
1 30.95 Pos Neg  – – – –
1 24.99 Neg  Neg  – – – –
1 29.21 Neg  Neg  – – – –
1 31.78 Neg  Neg  – – – –
1 35.83 Neg  Neg  – – – –
1 24.98 Pos Pos – – – –
1 35.5 Neg Pos – – – –
1 36.96 Neg  Neg  – – – –
1 32.21 Neg  Neg  – – – –
*Ct, cycle threshold; neg, negative; –, not applicable; ND, not done; pos, positive. 
†Rickettsial DNA was identified by using a fragment of the citrate synthase A gene that is conserved among all spotted fever group rickettsiae. 
‡Specific quantitative PCR was performed on the basis of epidemiologic data and tick bite history of each patient. 
§No cutaneous biopsy samples were available. 
¶Results for patient 9 correspond to results of re-amplification of products of the first PCRs. of vesicular lesions may be useful for diagnosis, although 
these lesions were less sensitive than eschars.
Our results indicate that swabs of eschars can be used 
for molecular detection of rickettsial infections when bi-
opsy samples are not available or biopsies are difﬁ  cult to 
perform. We recommend that swabs be used for DNA ex-
traction immediately after sampling or stored at 4°C until 
needed.
Acknowledgments
We thank L. Espinosa and M. Bedotto for help with statis-
tical analysis and design of primers and probe for R. australis 
detection.
This study was supported by the Hospital Clinical Research 
Program from the French Health Ministry (Recherche de Proté-
ines Candidates à la Mise au Point d’un Vaccin par Étude de la 
Transcription de Rickettsia conorii chez l’Homme au Cours de la 
Fièvre Boutonneuse Méditerranéenne) (2004).
Dr Bechah is a postdoctoral fellow at the Université de la 
Méditerranée, Marseille, France. Her research interests are epi-
demic typhus, its relapsing form (Brill-Zinsser disease), and the 
reservoir of this disease.
References
    1.   Bechah Y, Capo C, Mege JL, Raoult D. Rickettsial diseases: 
from  Rickettsia-arthropod relationships to pathophysiology and 
animal models. Future Microbiol. 2008;3:223–36. DOI: 10.2217/
17460913.3.2.223
  2.   Raoult D, Roux V. Rickettsioses as paradigms of new or emerging 
infectious diseases. Clin Microbiol Rev. 1997;10:694–719.
  3.   Walker DH, Valbuena GA, Olano JP. Pathogenic mechanisms of dis-
eases caused by Rickettsia. Ann N Y Acad Sci. 2003;990:1–11. DOI: 
10.1111/j.1749-6632.2003.tb07331.x
  4.   Parola P, Paddock CD, Raoult D. Tick borne rickettsioses around the 
world: emerging diseases challenging old concepts. Clin Microbiol 
Rev. 2005;18:719–56. DOI: 10.1128/CMR.18.4.719-756.2005
  5.   Paddock CD, Holman RC, Krebs JW, Childs JE. Assessing the mag-
nitude of fatal Rocky Mountain spotted fever in the United States: 
comparison of two national data sources. Am J Trop Med Hyg. 
2002;67:349–54.
  6.   Hidalgo M, Orejuela L, Fuya P, Carrillo P, Hernandez J, Parra E, 
et al. Rocky Mountain spotted fever, Colombia. Emerg Infect Dis. 
2007;13:1058–60.
  7.   Masters EJ, Olson GS, Weiner SJ, Paddock CD. Rocky Mountain 
spotted fever: a clinician’s dilemma. Arch Intern Med. 2003;163:769–
74. DOI: 10.1001/archinte.163.7.769
  8.   Raoult D. A new rickettsial disease in the United States. Clin Infect 
Dis. 2004;38:812–3. DOI: 10.1086/381896
  9.   Shapiro MR, Fritz CL, Tait K, Paddock CD, Nicholson WL, Abramo-
wicz KF, et al. Rickettsia 364D: a newly recognized cause of eschar-
associated illness in California. Clin Infect Dis. 2010;50:541–8. 
DOI: 10.1086/649926
10.   Wang JM, Hudson BJ, Watts MR, Karagiannis T, Fisher NJ, Ander-
son C, et al. Diagnosis of Queensland tick typhus and African tick 
bite fever by PCR of lesion swabs. Emerg Infect Dis. 2009;15:963–5. 
DOI: 10.3201/eid1506.080855
11.   Lee SH, Kim DM, Cho YS, Yoon SH, Shim SK. Usefulness of eschar 
PCR for diagnosis of scrub typhus. J Clin Microbiol. 2006;44:1169–
71. DOI: 10.1128/JCM.44.3.1169-1171.2006
12.  La Scola B, Bechah Y, Lepidi H, Raoult D. Prediction of rickettsial 
skin eschars in humans using an experimental guinea pig model. Mi-
crob Pathog. 2009;47:128–33. DOI: 10.1016/j.micpath.2009.06.004
13.   Bechah Y, Capo C, Grau GE, Raoult D, Mege JL. A murine model 
of infection with Rickettsia prowazekii: implications for pathogen-
esis of epidemic typhus. Microbes Infect. 2007;9:898–906. DOI: 
10.1016/j.micinf.2007.03.008
14.   Mediannikov O, Fenollar F, Socolovschi C, Diatta G, Sokhna C, 
Bassene H, et al. Coxiella burnetii in humans and ticks in rural 
Senegal. PLoS Negl Trop Dis. 2010;4:e654. DOI: 10.1371/journal.
pntd.0000654
15.   Roux V, Rydkina E, Eremeeva M, Raoult D. Citrate synthase gene 
comparison, a new tool for phylogenetic analysis, and its applica-
tion for the rickettsiae. Int J Syst Bacteriol. 1997;47:252–61. DOI: 
10.1099/00207713-47-2-252
Address for correspondence: Didier Raoult, Unité de recherche sur les 
maladies infectieuses et tropicales émergentes (URMITE), CNRS UMR 
6236, IRD 3R198, IFR 48, Université de la Méditerranée, Faculté de 
Médecine, 27 Boulevard Jean Moulin, 13385 Marseille CEDEX 05, 
France; email: didier.raoult@gmail.com
DISPATCHES
86  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 1, January 2011